Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paola Contini

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Leukemia Research|September 27, 2019
A simple cytofluorimetric score may optimize testing for biallelic CEBPA mutations in patients with acute myeloid leukemiaRiccardo Marcolin, Fabio Guolo, Paola Minetto, et al.
Frontiers in Molecular Biosciences|June 27, 2022
Lipoprotein(a) Modulates Carotid Atherosclerosis in Metabolic SyndromeAnna Laura Cremonini, Andrea Pasta, Federico Carbone, et al.
American Journal of Hematology|March 4, 2026
Cryopreservation of Hemopoietic Cells for Allotransplant: Altered Immune Cell Subsets and Clinical ImplicationsAnna Maria Raiola, Paola Contini, Massimiliano Gambella, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancersGilberto Filaci, Daniela Fenoglio, Marco Fravega, et al.
Blood Advances|September 11, 2020
Amino acid depletion triggered by ʟ-asparaginase sensitizes MM cells to carfilzomib by inducing mitochondria ROS-mediated cell deathDebora Soncini, Paola Minetto, Claudia Martinuzzi, et al.
Haematologica|October 15, 2020
The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programsDebora Soncini, Stefania Orecchioni, Samantha Ruberti, et al.
The Journal of Allergy and Clinical Immunology|July 14, 2022
Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatmentArinna Bertoni, Federica Penco, Hilaria Mollica, et al.
European Journal of Haematology|July 23, 2021
Pre-transplant minimal residual disease assessment and transplant-related factors predict the outcome of acute myeloid leukemia patients undergoing allogeneic stem cell transplantationFabio Guolo, Carmen Di Grazia, Paola Minetto, et al.
Haematologica|October 21, 2021
Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatmentDebora Soncini, Claudia Martinuzzi, Pamela Becherini, et al.
Immunity|October 3, 2025
Notch3 destabilizes regulatory T cells to drive autoimmune neuroinflammation in multiple sclerosisMehdi Benamar, Paola Contini, Klaus Schmitz-Abe, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Leukemia Research|September 27, 2019
A simple cytofluorimetric score may optimize testing for biallelic CEBPA mutations in patients with acute myeloid leukemiaRiccardo Marcolin, Fabio Guolo, Paola Minetto, et al.
Frontiers in Molecular Biosciences|June 27, 2022
Lipoprotein(a) Modulates Carotid Atherosclerosis in Metabolic SyndromeAnna Laura Cremonini, Andrea Pasta, Federico Carbone, et al.
American Journal of Hematology|March 4, 2026
Cryopreservation of Hemopoietic Cells for Allotransplant: Altered Immune Cell Subsets and Clinical ImplicationsAnna Maria Raiola, Paola Contini, Massimiliano Gambella, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancersGilberto Filaci, Daniela Fenoglio, Marco Fravega, et al.
Blood Advances|September 11, 2020
Amino acid depletion triggered by ʟ-asparaginase sensitizes MM cells to carfilzomib by inducing mitochondria ROS-mediated cell deathDebora Soncini, Paola Minetto, Claudia Martinuzzi, et al.
Haematologica|October 15, 2020
The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programsDebora Soncini, Stefania Orecchioni, Samantha Ruberti, et al.
The Journal of Allergy and Clinical Immunology|July 14, 2022
Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatmentArinna Bertoni, Federica Penco, Hilaria Mollica, et al.
European Journal of Haematology|July 23, 2021
Pre-transplant minimal residual disease assessment and transplant-related factors predict the outcome of acute myeloid leukemia patients undergoing allogeneic stem cell transplantationFabio Guolo, Carmen Di Grazia, Paola Minetto, et al.
Haematologica|October 21, 2021
Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatmentDebora Soncini, Claudia Martinuzzi, Pamela Becherini, et al.
Immunity|October 3, 2025
Notch3 destabilizes regulatory T cells to drive autoimmune neuroinflammation in multiple sclerosisMehdi Benamar, Paola Contini, Klaus Schmitz-Abe, et al.
Pageof 10